サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514144

心房細動デバイスの世界市場

Atrial Fibrillation Devices

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
心房細動デバイスの世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心房細動デバイスの世界市場は2030年までに159億米ドルに到達

2023年に71億米ドルと推定される心房細動デバイスの世界市場は、分析期間2023-2030年にCAGR 12.2％で成長し、2030年には159億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるEPアブレーションカテーテルは、CAGR 14.6％を記録し、分析期間終了までに48億米ドルに達すると予測されます。EP診断カテーテルセグメントの成長率は、分析期間でCAGR 11.4％と推定されます。

米国市場は19億米ドル、中国はCAGR17.0％で成長予測

米国の心房細動デバイス市場は2023年に19億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに38億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは17.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.6%と10.1%と予測されています。欧州では、ドイツがCAGR約9.5％で成長すると予測されています。

心房細動デバイス-主要動向と促進要因

心房細動（AF）は最も一般的なタイプの不整脈であり、心臓の心房室の急速で不規則な拍動を特徴とします。この状態は、脳卒中、心不全、その他の心血管系合併症のリスクを著しく高める。心房細動を管理・治療するために、カテーテルアブレーション装置、ペースメーカー、植え込み型除細動器（ICD）、左心房付属器（LAA）閉鎖装置など、さまざまな医療機器が使用されています。特にカテーテルアブレーションは、不規則なリズムの原因となっている心臓組織を破壊するために、カテーテルを通してエネルギーを供給するもので、心房細動に対する非常に効果的な治療法として注目されています。ペースメーカーやICDは、心臓のリズムを整え、突然の心停止を防ぐために使用されます。一方、LAA閉鎖装置は、心房細動患者によく見られる血栓ができる心臓の部位を塞ぐことで、脳卒中のリスクを減らすのに役立ちます。

最近の心房細動デバイスの進歩は、その有効性と安全性を著しく向上させています。クライオアブレーションやレーザーアブレーションの開発など、カテーテルアブレーション技術の革新は、患者にとってより正確で侵襲の少ない選択肢を提供しています。接触力を感知するカテーテルのイントロダクションはアブレーション手技の精度を高め、周囲へのダメージを最小限に抑えながら、より効果的な組織破壊を保証しています。さらに、イメージングとマッピング技術の進歩により、心臓の解剖学的構造と電気的活動がよりよく可視化されるようになり、アブレーション治療がより正確かつ成功するようになった。ペースメーカーやICDの小型化と電池寿命の向上は、これらの機器をより患者に優しいものとし、頻繁な交換の必要性を減らし、より侵襲の少ない植え込み手技を可能にしています。さらに、LAA閉鎖装置の設計改善により、成功率が高まり、合併症発生率も低下しています。

心房細動デバイス市場の成長は、いくつかの要因によってもたらされます。次世代アブレーションカテーテルや改良型イメージングシステムの開発など、医療技術の進歩は心房細動治療の成果を著しく向上させ、これらのデバイスの採用を促進しています。特に高齢化社会における心房細動の有病率の増加は、治療を必要とする患者層を拡大しています。さらに、未治療の心房細動に伴うリスクに対する意識の高まりや、高度な治療オプションの利用可能性が、より多くの患者に医療介入を求めるよう促しています。また、新興国市場におけるヘルスケア支出の増加や医療サービスへのアクセスの向上も市場拡大に寄与しています。さらに、医療機器業界の主要企業間の戦略的提携やパートナーシップは、技術革新を促進し、先進的な心房細動デバイスの利用可能性を拡大しています。人工知能（AI）や機械学習（ML）がこれらの機器の開発・開拓に統合されることで、診断・治療能力が強化され、市場がさらに活性化しています。これらの要因が相まって、心房細動デバイス市場の堅調な成長と継続的な進化が確実なものとなっています。

調査対象企業の例（注目の34社）

  • Abbott Laboratories, Inc.
  • AtriCure, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • OSYPKA AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6194

Global Atrial Fibrillation Devices Market to Reach US$15.9 Billion by 2030

The global market for Atrial Fibrillation Devices estimated at US$7.1 Billion in the year 2023, is expected to reach US$15.9 Billion by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. EP Ablation Catheters, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$4.8 Billion by the end of the analysis period. Growth in the EP Diagnostic Catheters segment is estimated at 11.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 17.0% CAGR

The Atrial Fibrillation Devices market in the U.S. is estimated at US$1.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 17.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 10.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Atrial Fibrillation Devices - Key Trends and Drivers

Atrial fibrillation (AF) is the most common type of cardiac arrhythmia, characterized by rapid and irregular beating of the atrial chambers of the heart. This condition significantly increases the risk of stroke, heart failure, and other cardiovascular complications. To manage and treat AF, a variety of medical devices are used, including catheter ablation devices, pacemakers, implantable cardioverter defibrillators (ICDs), and left atrial appendage (LAA) closure devices. Catheter ablation, in particular, has emerged as a highly effective treatment for AF, involving the delivery of energy through a catheter to destroy the heart tissue causing the irregular rhythm. Pacemakers and ICDs are used to regulate heart rhythms and prevent sudden cardiac arrest, while LAA closure devices help reduce the risk of stroke by sealing off the area of the heart where blood clots commonly form in AF patients.

Recent advancements in atrial fibrillation devices have significantly improved their efficacy and safety. Innovations in catheter ablation technology, such as the development of cryoablation and laser ablation, offer more precise and less invasive options for patients. The introduction of contact force-sensing catheters has enhanced the precision of ablation procedures, ensuring more effective tissue destruction while minimizing damage to surrounding areas. Moreover, advancements in imaging and mapping technologies have enabled better visualization of the heart's anatomy and electrical activity, leading to more accurate and successful ablation treatments. The miniaturization and enhanced battery life of pacemakers and ICDs have made these devices more patient-friendly, reducing the need for frequent replacements and allowing for less invasive implantation procedures. Additionally, the design improvements in LAA closure devices have resulted in higher success rates and lower complication rates.

The growth in the atrial fibrillation devices market is driven by several factors. Advances in medical technology, such as the development of next-generation ablation catheters and improved imaging systems, are significantly enhancing the outcomes of AF treatments and driving the adoption of these devices. The increasing prevalence of atrial fibrillation, particularly among the aging population, is expanding the patient base requiring treatment. Furthermore, growing awareness about the risks associated with untreated AF and the availability of advanced treatment options are encouraging more patients to seek medical intervention. Rise in healthcare expenditure and improved access to healthcare services in developing regions are also contributing to market growth. Additionally, strategic collaborations and partnerships among key players in the medical device industry are fostering innovation and expanding the availability of advanced AF devices. The integration of artificial intelligence (AI) and machine learning (ML) in the development and deployment of these devices is further propelling the market, offering enhanced diagnostic and therapeutic capabilities. These factors collectively ensure the robust growth and continued evolution of the atrial fibrillation devices market.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories, Inc.
  • AtriCure, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • OSYPKA AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Atrial Fibrillation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Catheter Ablation Technology Propel Growth in AF Devices Market
    • Increasing Prevalence of Atrial Fibrillation Expands Addressable Market Opportunity
    • Innovations in Imaging and Mapping Technologies Enhance Treatment Precision
    • Development of Next-Generation Pacemakers and ICDs Drives Adoption of AF Devices
    • Rising Awareness about Untreated AF Risks Spurs Demand for Advanced Treatments
    • Improved Access to Healthcare Services in Developing Regions Expands Market Reach
    • Integration of AI and Machine Learning in AF Devices Strengthens Diagnostic and Therapeutic Capabilities
    • Miniaturization and Enhanced Battery Life of Devices Strengthen Business Case for Implantable Solutions
    • Increasing Healthcare Expenditure Drives Adoption of Advanced AF Treatment Options
    • Development of Contact Force-Sensing Catheters Enhances Efficacy of Ablation Procedures
    • Expansion of Telemedicine and Remote Monitoring Solutions Accelerates Market Adoption
    • Growth of Aging Population Drives Demand for AF Management Solutions
    • Evolution of Patient-Centric Healthcare Models Generates Demand for Advanced AF Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Atrial Fibrillation Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Atrial Fibrillation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Atrial Fibrillation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for EP Ablation Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for EP Ablation Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for EP Ablation Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for EP Diagnostic Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for EP Diagnostic Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for EP Diagnostic Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for EP Mapping & Recording Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for EP Mapping & Recording Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for EP Mapping & Recording Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiac Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cardiac Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Cardiac Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Access Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for LAA Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for LAA Closure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for LAA Closure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for EP Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for EP Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for EP Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Surgical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Surgical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Surgical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Electrophysiology Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Electrophysiology Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Electrophysiology Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Atrial Fibrillation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Atrial Fibrillation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Atrial Fibrillation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Atrial Fibrillation Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Australia 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: India 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: India 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: India 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: South Korea 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Atrial Fibrillation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Atrial Fibrillation Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Latin America 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Argentina 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Brazil 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Mexico 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Rest of Latin America 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Atrial Fibrillation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Atrial Fibrillation Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Middle East 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Iran 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Israel 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Saudi Arabia 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: UAE 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Rest of Middle East 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Atrial Fibrillation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Atrial Fibrillation Devices by Type - EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Atrial Fibrillation Devices by Type - Percentage Breakdown of Value Sales for EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping & Recording Systems, Cardiac Monitors, Access Devices, LAA Closure and Other Types for the Years 2014, 2024 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Atrial Fibrillation Devices by Application - Diagnostics, EP Ablation and Surgical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Atrial Fibrillation Devices by Application - Percentage Breakdown of Value Sales for Diagnostics, EP Ablation and Surgical for the Years 2014, 2024 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Atrial Fibrillation Devices by End-Use - Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 316: Africa 16-Year Perspective for Atrial Fibrillation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Electrophysiology Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION